arav-8k_20210125.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 25, 2021

 

Aravive, Inc.

(Exact name of registrant as specified in its charter)

 

 

Delaware

 

001-36361

 

26-4106690

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

River Oaks Tower

3730 Kirby Drive, Suite 1200

Houston, Texas 77098

(Address of principal executive offices)

 

(936) 355-1910

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange
on which registered

Common stock, par value $0.0001 per share

 

ARAV

 

Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


Item 5.02.    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.

On January 25, 2021, Aravive, Inc. (the “Company”) entered into an amendment (the “McIntyre Amendment”), to the Offer Letter (the “McIntyre Offer Letter”) that it had entered into with Gail McIntyre, Ph.D., the Company’s Chief Executive Officer, on March 26, 2020, as amended on April 8, 2020. The McIntyre Amendment provides that Dr. McIntyre will receive: (i) effective as of January 1, 2021, an annual base salary of $500,000, less required deductions and withholdings, payable in accordance with the Company’s standard payroll schedule, for service as the Company’s Chief Executive Officer; and (ii) a target bonus equal to 50% of Dr. McIntyre’s annual base salary.  All other terms of the McIntyre Offer Letter shall remain in full force and effect. On January 25, 2021, Dr. McIntyre was also granted a cash bonus of $149,400 for the Company’s 2020 fiscal year and an option to purchase 165,000 shares of the Company’s common stock with an exercise price of $5.95 per share and vesting pro rata on a monthly basis over a four- year period.

The foregoing description of the McIntyre Amendment do not purport to be complete and are qualified in their entirety by reference to copy of the McIntyre Amendment, which are filed as Exhibit 10.1, to this Current Report on Form 8-K and are incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit

  

Description

 

 

10.1

  

Amendment to Offer Letter dated as of January 25, 2021 by and between Aravive, Inc. and Gail McIntyre, Ph.D.

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: January 27, 2021

ARAVIVE, INC.

(Registrant)

 

 

 

By:

 

/s/ Vinay Shah

 

 

 

Name: Vinay Shah

Title: Chief Financial Officer

 

arav-ex101_6.htm

Exhibit 10.1

 

River Oaks Tower

3730 Kirby Drive, Suite 1200

Houston, Texas 77098

 

Gail McIntyre

 

(via email: XXX)

 

 

 

 

January 25, 2021

 

Dear Gail:

Aravive, Inc. (the “Company”) is pleased to enter into this amendment (“Amendment”) to your Offer Letter, dated March 26, 2020, as amended on April 8, 2021 (the “Offer Letter”), and hereby agrees to amend the Offer Letter as follows:

1. The first sentence of Section 3 is hereby deleted and replaced with the following:

“Effective as of January 1, 2021, the Company will pay you a salary at the rate of Five Hundred Thousand Dollars ($500,000) per year, less required deductions and withholdings, payable in accordance with the Company’s standard payroll schedule.”

2.The third sentence of the second paragraph of Section 3 is hereby deleted and replaced with the following:

“For fiscal year 2021 your target bonus will be equal to 50% of your annual base salary (“Target Bonus”).”

3.All other terms of the Offer Letter shall remain in full force and effect. The Offer Letter, as amended by this Amendment, constitutes the entire agreement between the parties with respect to the subject matter thereof.

4.If any of the provisions of this Amendment are held to be invalid or unenforceable, the remaining provisions will nevertheless continue to be valid and enforceable.

5.This Amendment is made and shall be construed and performed under the laws of the State of Texas without regard to its choice or conflict of law principles and the parties agree to the State of Texas as the exclusive venue for any disputes arising hereunder.

 

Very truly yours,

 

Aravive Inc.

 

By:

 

/s/ Vinay Shah

Name:

 

Vinay Shah

Title:

 

Chief Financial Officer

 

I have read and accept this amended employment offer:

 

/s/ Gail McIntyre

Signature

 

 

 

Printed Name:

 

Gail McIntyre

 

 

 

Dated:

 

January 25, 2021